XML 19 R33.htm IDEA: XBRL DOCUMENT
v2.4.0.8

Investments in and Advances to Unconsolidated Joint Ventures (Tables) | 3 Months Ended
--- | ---
Mar. 31, 2014
Investments in and Advances to Unconsolidated Joint Ventures |
Company owned interests in entities, accounted under equity method | The Company owns interests in the following entities that are accounted for under the equity method at March 31, 2014 (dollars in thousands):
Entity(1) |  | Segment |  | Investment(2) |  | Ownership% |
HCR ManorCare |  | post-acute/skilled nursing |  | $ | 82,311 |  | 9.5 |
HCP Ventures III, LLC |  | medical office |  | 7,065 |  | 30 |
HCP Ventures IV, LLC |  | medical office and hospital |  | 29,074 |  | 20 |
HCP Life Science(3) |  | life science |  | 68,798 |  | 50-63 |
Suburban Properties, LLC |  | medical office |  | 6,180 |  | 67 |
Advances to unconsolidated joint ventures, net |  |  |  | 502 |  |  |
|  |  |  | $ | 193,930 |  |  |
Edgewood Assisted Living Center, LLC |  | senior housing |  | $ | (431 | ) |  |
Seminole Shores Living Center, LLC |  | senior housing |  | (656 | ) |  |
|  |  |  | $ | (1,087 | ) |  |
(1) These entities are not consolidated because the Company does not control, through voting rights or other means, the joint ventures. (2) Represents the carrying value of the Company’s investment in the unconsolidated joint venture. Negative balances are recorded in accounts payable and accrued liabilities on the Company’s Condensed Consolidated Balance Sheets. Includes a 72% interest in a senior housing partnership which has an investment balance of zero. (3) Includes three unconsolidated joint ventures between the Company and an institutional capital partner for which the Company is the managing member. HCP Life Science includes the following partnerships (and the Company’s ownership percentage): (i) Torrey Pines Science Center, LP (50%); (ii) Britannia Biotech Gateway, LP (55%); and (iii) LASDK, LP (63%).
Summarized combined financial information for unconsolidated joint ventures | Summarized combined financial information for the Company’s unconsolidated joint ventures follows (in thousands):
|  | March 31, |  | December 31, |
|  | 2014 |  | 2013 |
Real estate, net |  | $ | 3,644,045 |  | $ | 3,662,450 |
Goodwill and other assets, net |  | 5,414,544 |  | 5,384,553 |
Total assets |  | $ | 9,058,589 |  | $ | 9,047,003 |
Capital lease obligations and mortgage debt |  | $ | 6,736,980 |  | $ | 6,768,815 |
Accounts payable |  | 1,083,690 |  | 1,045,260 |
Other partners’ capital |  | 1,102,974 |  | 1,098,228 |
HCP’s capital(1) |  | 134,945 |  | 134,700 |
Total liabilities and partners’ capital |  | $ | 9,058,589 |  | $ | 9,047,003 |
(1) The combined basis difference of the Company’s investments in these joint ventures of $57 million, as of March 31, 2014, is primarily attributable to goodwill, real estate, capital lease obligations, deferred tax assets and lease-related net intangibles.
|  | Three Months Ended March 31, |
|  | 2014 |  | 2013 |
Total revenues |  | $ | 1,079,891 |  | $ | 1,093,374 |
Net income |  | 7,996 |  | 10,584 |
HCP’s share of earnings(1) |  | 14,528 |  | 14,801 |
Fees earned by HCP |  | 449 |  | 443 |
Distributions received by HCP |  | 3,202 |  | 1,371 |
(1) The Company’s joint venture interest in HCR ManorCare is accounted for using the equity method and results in an ongoing elimination of DFL income proportional to HCP’s ownership in HCR ManorCare. The elimination of the respective proportional lease expense at the HCR ManorCare level in substance results in $15.6 million and $15.9 million of DFL income that is recharacterized to the Company’s share of earnings from HCR ManorCare (equity income from unconsolidated joint ventures) for the three months ended March 31, 2014 and 2013, respectively.

X
- Definition Tabular disclosure of summarized financial information for the entity's unconsolidated joint ventures. + References No definition available. + Details
Name: | hcp_EquityMethodInvestmentsFinancialInformationTableTextBlock
Namespace Prefix: | hcp_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of equity method investments including, but not limited to, name of each investee or group of investments, percentage ownership, difference between recorded amount of an investment and the value of the underlying equity in the net assets, and summarized financial information. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 323 -SubTopic 10 -Section 50 -Paragraph 3 -URI http://asc.fasb.org/extlink&oid=6382943&loc=d3e33918-111571 + Details
Name: | us-gaap_EquityMethodInvestmentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration